Literature DB >> 16044085

Effects of bovine polymerized hemoglobin on coagulation in controlled hemorrhagic shock in swine.

Françoise Arnaud1, Mike Hammett, Ludmila Asher, Nora Philbin, Jennifer Rice, Feng Dong, Bruce Pearce, William S Flournoy, Carol Nicholson, Richard McCarron, Daniel Freilich.   

Abstract

HBOC-201, a bovine polymerized hemoglobin, has been proposed as a novel oxygen-carrying resuscitative fluid for patients with hemorrhagic shock (HS). Herein, we evaluated the hemostatic effects of HBOC-201 in an animal model of HS. A 40% blood loss-controlled hemorrhage and soft tissue injury were performed in 24 invasively monitored Yucatan mini-pigs. Pigs were resuscitated with HBOC-201 (HBOC) or hydroxyethyl starch (HEX), or were not resuscitated (NON) based on cardiac parameters during a 4-h prehospital phase. Afterward, animals received simulated hospital care for 3 days with blood or saline transfusions. Hemostasis measurements included in vivo bleeding time (BT), thromboelastography (TEG), in vitro bleeding time (platelet function; PFA-CT), prothrombin time (PT), and partial thromboplastin time (PTT). Serum lactate was measured and lung sections were evaluated for microthrombi by electron microscopy. During the prehospital phase, BT remained unchanged in the HBOC group. TEG reaction time increased in HBOC pigs during the late prehospital phase and was greater than in NON or HEX pigs at 24 h (P = 0.03). TEG maximum amplitude was similar for the two fluid-resuscitated groups. PFA-CT increased in both resuscitated groups but less with HBOC (P = 0.02) in the prehospital phase; this effect was reversed by 24 h (P = 0.02). In the hospital phase, PT decreased (P < 0.02), whereas PTT increased above baseline (P < 0.01). Lactic acidosis in HBOC and HEX groups was similar. Aspartate aminotransferase was relatively elevated in the HBOC group at 24 h. Electron microscopy showed no evidence of platelet/fibrin clots or microthrombi in any of the animals. Twenty-four-hour group differences mainly reflected the fact that all HEX animals (8/8) received blood transfusions compared with only one HBOC animal (1/8). In swine with HS, HBOC resuscitation induced less thrombopathy than HEX during the prehospital phase. Mild delayed effects on platelet and clot formation during the hospital phase are transient and likely related to fewer blood transfusions. In swine with HS, HBOC resuscitation induced less thrombopathy than HEX during the prehospital phase but more thrombopathy in the hospital phase. The delayed effects on platelet and clot formation during the hospital phase are transient and may be related to the need for fewer blood transfusions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044085     DOI: 10.1097/01.shk.0000170354.18437.2f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Emergency surgery of the abdominal aorta in a porcine model: two sequential experiments.

Authors:  Francisco S Lozano; José M Rodríguez; Francisco J García-Criado; Jose R Gonzalez-Porras; Fermin M Sanchez-Guijo; Pilar Sanchez-Conde; Jose E García-Sanchez
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

2.  Glutaraldehyde-polymerized bovine hemoglobin and phosphodiesterase-5 inhibition.

Authors:  Robert W Gotshall; Karyn L Hamilton; Benjamin Foreman; Martha C Tissot van Patot; David C Irwin
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

Review 3.  Fluid resuscitation: past, present, and the future.

Authors:  Heena P Santry; Hasan B Alam
Journal:  Shock       Date:  2010-03       Impact factor: 3.454

Review 4.  Effects of hemoglobin-based oxygen carriers on blood coagulation.

Authors:  Kimia Roghani; Randall J Holtby; Jonathan S Jahr
Journal:  J Funct Biomater       Date:  2014-12-12

Review 5.  Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.

Authors:  Kazuaki Taguchi; Keishi Yamasaki; Toru Maruyama; Masaki Otagiri
Journal:  J Funct Biomater       Date:  2017-03-18

Review 6.  Bench-to-bedside review: latest results in hemorrhagic shock.

Authors:  Martin K Angele; Christian P Schneider; Irshad H Chaudry
Journal:  Crit Care       Date:  2008-07-10       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.